Stock 002550 CHANGZHOU QIANHONG BIOPHARMA CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Changzhou Qianhong Biopharma CO.,LTD

Equities

002550

CNE100001070

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 05/05/2024 BST 		5-day change 1st Jan Change
5.6 CNY +4.87% Intraday chart for Changzhou Qianhong Biopharma CO.,LTD +7.90% -4.76%
04-25 Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-22 Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on January 3, 2024. CI

Business Summary

Changzhou Qianhong Biopharma CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of freeze-drying powder, freeze-drying powder injections, small volume injections, tablets, hard capsules, granules and bulk drugs, among others. The Company mainly provides liquaemin sodium raw materials and preparations, applied to prevent and treat thromboembolism desease; kallidinogen preparations, applied in the treatment of micro-circulation disorder disease, asparaginase bulk drugs and preparations, applied in the treatment of acute lymphoblastic leukemia, as well as compound digestive enzyme capsules II. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 1,102

Sales per Business

CNY in Million2022Weight2023Weight Delta
Preparation Series
61.4 %
1,182 51.3 % 1,115 61.4 % -5.67%
Active Pharmaceutical Ingredient Series
38.1 %
1,117 48.5 % 692 38.1 % -38.03%
Other
0.4 %
5 0.2 % 8 0.4 % +47.88%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
69.3 %
1,308 56.8 % 1,257 69.3 % -3.89%
Foreign
30.7 %
995 43.2 % 557 30.7 % -44.04%

Managers

Managers TitleAgeSince
Ke Wang CEO
 Chief Executive Officer 41 09/09/14
Ai Qun Xiao DFI
 Director of Finance/CFO 52 20/04/17
Wen Qun Jiang CHM
 Chairman 56 27/01/08
Xiang Zhou BRD
 Director/Board Member 42 17/08/17
Yong Fan BRD
 Director/Board Member 56 27/01/08
Yi Yao IRC
 Investor Relations Contact 42 27/01/21
Tao Hai PRN
 Corporate Officer/Principal 55 09/09/14
Li Jun Wei PRN
 Corporate Officer/Principal 52 -

Members of the board

Members of the board TitleAgeSince
Yao Fang Wang CHM
 Chairman 71 27/01/08
Gang Zhao BRD
 Director/Board Member 59 27/01/08
Yong Fan BRD
 Director/Board Member 56 27/01/08
Jian Ping Jiang BRD
 Director/Board Member 60 09/09/14
Jun Liu BRD
 Director/Board Member 57 27/01/08
Ke Wang CEO
 Chief Executive Officer 41 09/09/14
Guang Hua Xu BRD
 Director/Board Member 61 27/01/21
Tao Hai PRN
 Corporate Officer/Principal 55 09/09/14
Lei Chen BRD
 Director/Board Member 39 21/09/17
Xiang Zhou BRD
 Director/Board Member 42 17/08/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,279,800,000 766,752,256 ( 59.91 %) 30,000,000 ( 2.344 %) 59.91 %

Shareholders

NameEquities%Valuation
Yao Fang Wang
6.880 %
63,850,500 6.880 % 43 M ¥
Changzhou Qianhong Biopharma Co. Ltd. ESOP
3.232 %
30,000,000 3.232 % 20 M ¥
Ren Yi Zhao
3.125 %
29,000,000 3.125 % 20 M ¥
Guan Xin Zhou
2.747 %
25,500,000 2.747 % 17 M ¥
Techsharpe Quant (Beijing) Capital Management Co. Ltd.
2.090 %
19,400,000 2.090 % 13 M ¥
Gang Zhao
1.867 %
17,325,250 1.867 % 12 M ¥
Ke Wang
1.708 %
15,852,400 1.708 % 11 M ¥
Lun Qing Qun
1.636 %
15,180,000 1.636 % 10 M ¥
Jian Ping Jiang
1.147 %
10,641,750 1.147 % 7 M ¥
Fullgoal Fund Management Co., Ltd.
0.7754 %
7,196,872 0.7754 % 5 M ¥
NameEquities%Valuation
Yao Fang Wang
53.46 %
191,551,500 53.46 % 130 M ¥
Gang Zhao
14.51 %
51,975,750 14.51 % 35 M ¥
Ke Wang
13.27 %
47,557,200 13.27 % 32 M ¥
Jian Ping Jiang
8.911 %
31,925,250 8.911 % 22 M ¥
Jun Liu
5.036 %
18,044,733 5.036 % 12 M ¥

Company contact information

Changzhou Qianhong Biopharma Co., Ltd.

518, Yunhe Road Xinbei District

213125, Changzhou

+

http://www.qhsh.com.cn
address Changzhou Qianhong Biopharma CO.,LTD(002550)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Changzhou Qianhong Biopharma CO.,LTD

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.6 CNY
Average target price
6.12 CNY
Spread / Average Target
+9.29%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD Stock Changzhou Qianhong Biopharma CO.,LTD
-4.76% 941M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.96% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.81% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.63% 194B
AMGEN INC. Stock Amgen Inc.
+3.98% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002550 Stock
  4. Company Changzhou Qianhong Biopharma CO.,LTD